Encephaloduroarteriosynangiosis
| Encephaloduroarteriosynangiosis | |
|---|---|
| Other names | Encephalo-duro-arterio-synangiosis |
| Specialty | Neurology |
In medicine, encephaloduroarteriosynangiosis or EDAS[1] is a medical procedure for revascularization of the human brain using neurosurgery, primarily used to treat moyamoya syndrome or severe intracranial atherosclerotic disease, and to help prevent strokes and transient ischemic attacks.[2][3][4]
Procedure
A section of the superficial temporal artery and its surrounding tissue are carefully separated and preserved. After, a craniotomy is performed accessing the brain and exposing the dura mater through a small opening made in the skull. Then, the preserved artery is sutured to the edges of the dura mater and redirected onto the hypoxic portion of the brain's surface. The procedure is finished by reattaching the bone flap to the skull securing it with metal plates.[5][6]
Recovery
Over several weeks to a year, the body responds to the lack of blood flow by stimulating angiogenesis, which enables formation of new, healthy blood vessels from the placed artery onto the brain's surface.[3][7][8]
Patients spend their first night in the ICU, where blood pressure is strictly monitored to prevent strokes while blood vessels regrow, followed by a few days in a regular neuroscience unit.[7][9][10] Pain medication is optional, but usually provided to manage soreness and post-operative craniotomy headaches.[3] Antiplatelet medications are typically provided to prevent blood clots during the recovery window.[10]
Young children who undergo EDAS must be prevented from hyperventilation, as rapid breathing can trigger transient ischemic attacks before new blood vessels are fully grown.[11]
Unlike most brain surgeries, EDAS generally does not require rehabilitation.[3]
References
- ↑ Matsushima, T.; Fukui, M.; Kitamura, K.; Hasuo, K.; Kuwabara, Y.; Kurokawa, T. (1990). "Encephalo-duro-arterio-synangiosis in children with moyamoya disease". Acta Neurochirurgica. 104 (3–4): 96–102. doi:10.1007/BF01842826. ISSN 0001-6268. PMID 2251949.
- ↑ Gonzalez, Nestor R.; Dusick, Joshua R.; Connolly, Mark; Bounni, Firas; Martin, Neil A.; Van de Wiele, Barbara; Liebeskind, David S.; Saver, Jeffrey L. (2015). "Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations". Journal of Neurosurgery. 123 (3): 654–661. doi:10.3171/2014.10.JNS141426. PMID 26067617.
[EDAS] is a form of revascularization that has shown promising early results in the treatment of adult patients with moyamoya disease [and, more recently,] in patients with intracranial atherosclerotic steno-occlusive disease (ICASD).
- 1 2 3 4 "Encephaloduroarteriosynangiosis (EDAS)". Columbia Neurosurgery in New York City. 8 April 2021. Retrieved 4 February 2026.
- ↑ Ross, Ian B.; Shevell, Michael I.; Montes, Jose L.; Rosenblatt, Bernard; Watters, Gordon V.; Farmer, Jean-Pierre; O'Gorman, Augustin M. (1994-05-01). "Encephaloduroarteriosynangiosis (EDAS) for the treatment of childhood moyamoya disease". Pediatric Neurology. 10 (3): 199–204. doi:10.1016/0887-8994(94)90023-X. ISSN 0887-8994. PMID 8060421.
[EDAS] involves the transposition of a segment of a scalp artery onto the surface of the [brain. Such surgical] treatment [is] aimed at improving collateral blood flow.
- ↑ Nguyen, V. N.; Parikh, K. A.; Motiwala, M.; Erin Miller, L.; Barats, M.; Milton, C.; Khan, N. R. (2022). "Surgical techniques and indications for treatment of adult moyamoya disease". Front. Surg. 9 966430. doi:10.3389/fsurg.2022.966430. PMC 9437590. PMID 36061058.
- ↑ Wang, X. P.; Ren, B.; Wang, Q. N.; Li, J. J.; Liu, J. Q.; Yu, D.; Zhang, Q.; Bao, X. Y.; Zhang, J. N.; Duan, L. (18 July 2024). "Encephaloduroarteriosynangiosis for Symptomatic Intracranial Atherosclerotic Arterial Steno-Occlusive Disease: Clinical and Radiological Outcomes". Journal of the American Heart Association. 13 (15) e034707: 15. doi:10.1161/JAHA.124.034707. PMC 11964043. PMID 39023071.
- 1 2 Wang, Q. N.; Zou, Z. X.; Wang, X. P.; Zhang, Q.; Zhao, Y. Q.; Duan, L.; Bao, X. Y. (2021). "Endothelial Progenitor Cells Induce Angiogenesis: a Potential Mechanism Underlying Neovascularization in Encephaloduroarteriosynangiosis". Translational Stroke Research. 12, 2 (2): 357–365. doi:10.1007/s12975-020-00834-9. PMID 32632776.
- ↑ Guo, X.; Yuan, X.; Gao, L.; Chen, Y.; Yu, H.; Chen, W.; Yang, Y.; Chong, Z.; Sun, Z.; Jin, F.; Liu, D. (2021). "Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging". European Radiology. 31 (11): 8364–8373. doi:10.1007/s00330-021-07960-4. PMID 33956177.
- ↑ Chauhan, V. (2026). "Anesthetic Management for Encephaloduroarteriosynangiosis in Moyamoya Disease: A Hemodynamic and Neuromonitoring-Integrated Framework". Journal of Clinical Medicine. 15 (13): 4954. doi:10.3390/jcm15134954. PMC 13361196. PMID 42452416.
- 1 2 "Post Operative Care for Moyamoya Surgery". Stanford Medicine. Retrieved 18 July 2026.
- ↑ Karsonovich, T.; Lui, F. (2026). Moyamoya Disease. Treasure Island (FL): StatPearls Publishing. PMID 30571076. Retrieved 18 July 2026.